{
  "nctId": "NCT03154307",
  "briefTitle": "Repeated TMS at Low Frequencies to Reduce Seizure Occurrence",
  "officialTitle": "Repeated TMS at Low Frequencies to Reduce Seizure Occurrence",
  "protocolDocument": {
    "nctId": "NCT03154307",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-09-21",
    "uploadDate": "2022-10-03T10:49",
    "size": 808781,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03154307/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 2,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-02-19",
    "completionDate": "2019-08-23",
    "primaryCompletionDate": "2019-08-23",
    "firstSubmitDate": "2017-05-10",
    "firstPostDate": "2017-05-16"
  },
  "eligibilityCriteria": {
    "criteria": "Long-term protocol:\n\nInclusion Criteria:\n\n* Experience â‰¥ 3 seizures/month in the month prior to starting study (any type of seizure will count)\n* No status epilepticus in the last 12 months\n* No change in medication in last 30 days\n\nExclusion Criteria:\n\n* Presence of implanted electronic devices (e.g., pacemaker, medication pump, brain or vagus nerve stimulator, cochlear implant)\n* Presence of intracranial metal (e.g., aneurysm clip)\n* Unable to cooperate with non-sedated, navigated TMS testing\n\nShort-term protocol:\n\nInclusion Criteria:\n\n* Epilepsia partialis continua or status epilepticus\n* At least 2 medications failed\n* At least 24 hours of acute phase\n\nExclusion Criteria:\n\n* Presence of implanted electronic devices (e.g., pacemaker, medication pump, brain or vagus nerve stimulator, cochlear implant)\n* Presence of intracranial metal (e.g., aneurysm clip)",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "80 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Average Weekly Seizure Frequency",
        "description": "Seizure frequency was recorded by the caregiver in a journal at weeks 6 and 7 post rTMS treatment.",
        "timeFrame": "6 and 7 weeks post rTMS treatment"
      },
      {
        "measure": "Scalp EEG: Number of Interictal Epileptiform Discharges",
        "description": "Interictal discharges are common in those with epilepsy and tends to decrease with treatment.",
        "timeFrame": "From start of intervention through 5 days of treatment"
      },
      {
        "measure": "Seizure Duration Proxy for Seizure Severity",
        "description": "Care provider journaled the seizure duration over the coure of a 2-week period beginning on week 6 post rTMS treatment.",
        "timeFrame": "6-7-weeks post rTMS treatment"
      }
    ],
    "secondary": [
      {
        "measure": "Interhemispheric EEG Asymmetry Ratio for Alpha Power",
        "description": "Expresses the ratio of laterality for the corresponding electrode pairs between the left and right hemispheres, where the left hemisphere electrodes are divided by the right hemisphere electrodes.",
        "timeFrame": "8-weeks Post rTMS Treatment"
      },
      {
        "measure": "Scalp EEG Functional Connectivity for Alpha Hz",
        "description": "Standardized functional scalp EEG connection per of region (anterior, posterior, right, and left). Calculations required EEG electrode activity of 80% for a minimum of 20 epochs to be included. All area electrode counts were then divided by the threshold providing a normalized value per brain region. Scalp EEG connectivity was collected 8-weeks post rTMS treatment.",
        "timeFrame": "8-weeks Post rTMS Treatment"
      },
      {
        "measure": "Abductor Pollicis Brevis (APB)-Evoked Response Threshold",
        "description": "The motor evoked potential (MEP) will be calculated using the Nexstim system's 6-channel EMG module (SR=1450 Hz, cut-off frequency of 350 Hz for the low pass filter) as the APB is stimulated to find the threshold for each individual. Listed values represent the percentage of the maximum Tesla output of the Nexstim system.",
        "timeFrame": "8-weeks Post rTMS treatment"
      },
      {
        "measure": "Treatment Response Rate",
        "description": "Count of subjects whose seizure frequency decreased by 50% after rTMS treatment",
        "timeFrame": "8-weeks post rTMS treatment"
      },
      {
        "measure": "Intrahemispheric EEG Asymmetry Ratio for Alpha Power",
        "description": "Expresses the asymmetry power ratio for the corresponding electrode pairs between the posterior and anterior brain regions, where the left posterior electrodes are divided by the anterior electrodes.",
        "timeFrame": "8-weeks Post rTMS Treatment"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 3,
      "secondaryCount": 5,
      "otherCount": 0,
      "totalCount": 8
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 84,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:49.708Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}